More about
Ataxia Telangiectasia
News
October 03, 2023
1 min read
Save
FDA removes partial clinical hold on IND for rare pediatric disease drug-device combo
A Bay Area biotech company announced the FDA has lifted the partial clinical hold on EryDel SpA’s investigational new drug application for EryDex to treat ataxia-telangiectasia, a rare pediatric neurological disorder.